Multislice CT complements ultrasound in GI staging

Article

While both multislice CT and endoscopic ultrasound can evaluate local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam. It thus provides superior staging of T3 and T4 cancers, according to a study presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.

While both multislice CT and endoscopic ultrasound can evaluate local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam. It thus provides superior staging of T3 and T4 cancers, according to a study presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.

Dr. Ahmed Ba-Ssalamah and colleagues at the Medical University of Vienna enrolled 23 patients with esophageal carcinoma. The patients underwent endoscopic sonography and contrast-enhanced MSCT using a gas-water GI-filling technique.

Endoscopic ultrasound and MSCT each provided 100% sensitivity for tumor detection, but the sensitivity of other end points varied. Ultrasound was favored for tumor staging (89% versus 79%) and for diagnosis of local node involvement (82% versus 76%). CT was better in diagnosing distant node involvement and other metastases (65% versus 92%).

MSCT offers a field-of-view depth superior to endoscopic ultrasound for staging and detection of local disease and distant lymph node metastases, but it isn't perfect. Differentiation between T1 and T2 stages using the bowel distention-plus contrast technique is difficult, if not impossible. And MSCT's spatial resolution is still inferior to endoscopic ultrasound.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.